Shanghai Jiaoda Onlly Co Ltd (600530) - Net Assets
Based on the latest financial reports, Shanghai Jiaoda Onlly Co Ltd (600530) has net assets worth CN¥371.55 Million CNY (≈ $54.37 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥733.99 Million ≈ $107.41 Million USD) and total liabilities (CN¥362.45 Million ≈ $53.04 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check financial resilience of Shanghai Jiaoda Onlly Co Ltd to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥371.55 Million |
| % of Total Assets | 50.62% |
| Annual Growth Rate | 3.03% |
| 5-Year Change | -57.0% |
| 10-Year Change | -80.87% |
| Growth Volatility | 79.43 |
Shanghai Jiaoda Onlly Co Ltd - Net Assets Trend (1998–2024)
This chart illustrates how Shanghai Jiaoda Onlly Co Ltd's net assets have evolved over time, based on quarterly financial data. Also explore balance sheet size of Shanghai Jiaoda Onlly Co Ltd for the complete picture of this company's asset base.
Annual Net Assets for Shanghai Jiaoda Onlly Co Ltd (1998–2024)
The table below shows the annual net assets of Shanghai Jiaoda Onlly Co Ltd from 1998 to 2024. For live valuation and market cap data, see Shanghai Jiaoda Onlly Co Ltd market cap and net worth.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥375.21 Million ≈ $54.90 Million |
+10.62% |
| 2023-12-31 | CN¥339.18 Million ≈ $49.63 Million |
-8.40% |
| 2022-12-31 | CN¥370.29 Million ≈ $54.19 Million |
-59.47% |
| 2021-12-31 | CN¥913.57 Million ≈ $133.68 Million |
+4.69% |
| 2020-12-31 | CN¥872.63 Million ≈ $127.69 Million |
+10.16% |
| 2019-12-31 | CN¥792.15 Million ≈ $115.92 Million |
-19.42% |
| 2018-12-31 | CN¥983.07 Million ≈ $143.85 Million |
-43.71% |
| 2017-12-31 | CN¥1.75 Billion ≈ $255.57 Million |
-1.33% |
| 2016-12-31 | CN¥1.77 Billion ≈ $259.02 Million |
-9.75% |
| 2015-12-31 | CN¥1.96 Billion ≈ $287.01 Million |
-11.55% |
| 2014-12-31 | CN¥2.22 Billion ≈ $324.49 Million |
+51.95% |
| 2013-12-31 | CN¥1.46 Billion ≈ $213.55 Million |
-4.36% |
| 2012-12-31 | CN¥1.53 Billion ≈ $223.29 Million |
+8.06% |
| 2011-12-31 | CN¥1.41 Billion ≈ $206.64 Million |
+27.40% |
| 2010-12-31 | CN¥1.11 Billion ≈ $162.20 Million |
+20.28% |
| 2009-12-31 | CN¥921.58 Million ≈ $134.86 Million |
-5.65% |
| 2008-12-31 | CN¥976.75 Million ≈ $142.93 Million |
-14.86% |
| 2007-12-31 | CN¥1.15 Billion ≈ $167.88 Million |
+4.55% |
| 2006-12-31 | CN¥1.10 Billion ≈ $160.58 Million |
+1.88% |
| 2005-12-31 | CN¥1.08 Billion ≈ $157.61 Million |
+2.43% |
| 2004-12-31 | CN¥1.05 Billion ≈ $153.87 Million |
+3.26% |
| 2003-12-31 | CN¥1.02 Billion ≈ $149.02 Million |
+11.00% |
| 2002-12-31 | CN¥917.46 Million ≈ $134.25 Million |
+1.90% |
| 2001-12-31 | CN¥900.32 Million ≈ $131.74 Million |
+398.25% |
| 2000-12-31 | CN¥180.69 Million ≈ $26.44 Million |
-10.17% |
| 1999-12-31 | CN¥201.14 Million ≈ $29.43 Million |
+16.58% |
| 1998-12-31 | CN¥172.53 Million ≈ $25.25 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Shanghai Jiaoda Onlly Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 5810.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | CN¥774.92 Million | 237.92% |
| Other Comprehensive Income | CN¥163.04 Million | 50.06% |
| Other Components | CN¥33.63 Million | 10.32% |
| Total Equity | CN¥325.71 Million | 100.00% |
Shanghai Jiaoda Onlly Co Ltd Competitors by Market Cap
The table below lists competitors of Shanghai Jiaoda Onlly Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Autohellas S.A.
AT:OTOEL
|
$613.49 Million |
|
Shanghai Labway Clinical Laboratory Co Ltd
SHE:301060
|
$613.63 Million |
|
Plan B Media PCL
BK:PLANB
|
$613.70 Million |
|
Shanghai Yanhua Smartech Group
SHE:002178
|
$613.80 Million |
|
Caina Technology Co. Ltd.
SHE:301122
|
$613.21 Million |
|
Jing Jin Electric Technologies Co Ltd
SHG:688280
|
$613.21 Million |
|
Zhejiang Henglin Chair Industry Co Ltd Class A
SHG:603661
|
$613.14 Million |
|
Evergent Investments SA
RO:EVER
|
$613.06 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Shanghai Jiaoda Onlly Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 294,789,513 to 325,711,012, a change of 30,921,499 (10.5%).
- Net income of 30,481,364 contributed positively to equity growth.
- Dividend payments of 1,852,949 reduced retained earnings.
- Other comprehensive income increased equity by 141,554,681.
- Other factors decreased equity by 139,261,597.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥30.48 Million | +9.36% |
| Dividends Paid | CN¥1.85 Million | -0.57% |
| Other Comprehensive Income | CN¥141.55 Million | +43.46% |
| Other Changes | CN¥-139.26 Million | -42.76% |
| Total Change | CN¥- | 10.49% |
Book Value vs Market Value Analysis
This analysis compares Shanghai Jiaoda Onlly Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 12.66x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 24.86x to 12.66x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1998-12-31 | CN¥0.22 | CN¥5.41 | x |
| 1999-12-31 | CN¥0.25 | CN¥5.41 | x |
| 2000-12-31 | CN¥0.23 | CN¥5.41 | x |
| 2001-12-31 | CN¥1.14 | CN¥5.41 | x |
| 2002-12-31 | CN¥1.15 | CN¥5.41 | x |
| 2003-12-31 | CN¥1.22 | CN¥5.41 | x |
| 2004-12-31 | CN¥1.21 | CN¥5.41 | x |
| 2005-12-31 | CN¥1.22 | CN¥5.41 | x |
| 2006-12-31 | CN¥1.23 | CN¥5.41 | x |
| 2007-12-31 | CN¥1.57 | CN¥5.41 | x |
| 2008-12-31 | CN¥1.02 | CN¥5.41 | x |
| 2009-12-31 | CN¥1.11 | CN¥5.41 | x |
| 2010-12-31 | CN¥1.39 | CN¥5.41 | x |
| 2011-12-31 | CN¥1.74 | CN¥5.41 | x |
| 2012-12-31 | CN¥1.89 | CN¥5.41 | x |
| 2013-12-31 | CN¥1.70 | CN¥5.41 | x |
| 2014-12-31 | CN¥2.67 | CN¥5.41 | x |
| 2015-12-31 | CN¥2.35 | CN¥5.41 | x |
| 2016-12-31 | CN¥2.14 | CN¥5.41 | x |
| 2017-12-31 | CN¥2.10 | CN¥5.41 | x |
| 2018-12-31 | CN¥1.16 | CN¥5.41 | x |
| 2019-12-31 | CN¥0.97 | CN¥5.41 | x |
| 2020-12-31 | CN¥1.08 | CN¥5.41 | x |
| 2021-12-31 | CN¥1.13 | CN¥5.41 | x |
| 2022-12-31 | CN¥0.42 | CN¥5.41 | x |
| 2023-12-31 | CN¥0.42 | CN¥5.41 | x |
| 2024-12-31 | CN¥0.43 | CN¥5.41 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Shanghai Jiaoda Onlly Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 9.36%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 9.37%
- • Asset Turnover: 0.43x
- • Equity Multiplier: 2.33x
- Recent ROE (9.36%) is above the historical average (-1.94%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1998 | 30.14% | 13.84% | 1.01x | 2.16x | CN¥34.23 Million |
| 1999 | 30.27% | 11.55% | 1.15x | 2.27x | CN¥39.99 Million |
| 2000 | 28.09% | 10.56% | 1.07x | 2.49x | CN¥32.60 Million |
| 2001 | 6.14% | 12.05% | 0.39x | 1.32x | CN¥-34.32 Million |
| 2002 | 5.69% | 10.73% | 0.36x | 1.49x | CN¥-38.69 Million |
| 2003 | 5.96% | 8.94% | 0.40x | 1.68x | CN¥-38.63 Million |
| 2004 | 3.29% | 4.19% | 0.49x | 1.59x | CN¥-63.49 Million |
| 2005 | 3.27% | 8.89% | 0.19x | 1.98x | CN¥-64.12 Million |
| 2006 | 4.17% | 7.95% | 0.29x | 1.79x | CN¥-56.19 Million |
| 2007 | 0.51% | 0.90% | 0.34x | 1.67x | CN¥-95.45 Million |
| 2008 | -17.63% | -42.10% | 0.20x | 2.12x | CN¥-219.53 Million |
| 2009 | 3.20% | 8.41% | 0.28x | 1.36x | CN¥-56.44 Million |
| 2010 | 5.48% | 17.11% | 0.26x | 1.24x | CN¥-47.88 Million |
| 2011 | 4.08% | 15.84% | 0.21x | 1.24x | CN¥-80.56 Million |
| 2012 | 5.65% | 22.16% | 0.20x | 1.26x | CN¥-63.90 Million |
| 2013 | 6.27% | 22.61% | 0.20x | 1.35x | CN¥-49.46 Million |
| 2014 | 4.07% | 21.85% | 0.14x | 1.33x | CN¥-123.64 Million |
| 2015 | 5.41% | 37.00% | 0.10x | 1.47x | CN¥-84.11 Million |
| 2016 | 8.24% | 51.04% | 0.11x | 1.48x | CN¥-29.40 Million |
| 2017 | 9.82% | 56.88% | 0.12x | 1.38x | CN¥-2.99 Million |
| 2018 | -56.03% | -194.58% | 0.18x | 1.59x | CN¥-596.36 Million |
| 2019 | -9.41% | -20.70% | 0.24x | 1.88x | CN¥-146.08 Million |
| 2020 | 10.72% | 26.91% | 0.26x | 1.55x | CN¥6.04 Million |
| 2021 | 4.24% | 10.25% | 0.27x | 1.54x | CN¥-50.41 Million |
| 2022 | -151.47% | -132.15% | 0.43x | 2.69x | CN¥-531.33 Million |
| 2023 | -11.90% | -11.84% | 0.36x | 2.77x | CN¥-64.56 Million |
| 2024 | 9.36% | 9.37% | 0.43x | 2.33x | CN¥-2.09 Million |
Industry Comparison
This section compares Shanghai Jiaoda Onlly Co Ltd's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $4,691,234,838
- Average return on equity (ROE) among peers: 6.16%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Shanghai Jiaoda Onlly Co Ltd (600530) | CN¥371.55 Million | 30.14% | 0.98x | $613.47 Million |
| Shenzhen Neptunus Bioengineering Co Ltd (000078) | $903.62 Million | 4.28% | 2.45x | $1.16 Billion |
| Anhui Fengyuan Pharmaceutical Co Ltd (000153) | $1.22 Billion | 5.35% | 1.27x | $441.99 Million |
| Shan Dong Dong-E E-Jiao Co Ltd (000423) | $9.87 Billion | 20.71% | 0.25x | $5.01 Billion |
| Livzon Pharmaceutical Group Inc (000513) | $1.07 Billion | 3.83% | 0.46x | $2.80 Billion |
| Wedge Industrial Co Ltd (000534) | $1.15 Billion | 11.42% | 1.59x | $3.04 Billion |
| Yunnan Baiyao Group Co Ltd (000538) | $9.03 Billion | 25.71% | 0.43x | $13.75 Billion |
| Hainan Haiyao Co Ltd (000566) | $275.57 Million | 17.28% | 1.12x | $947.33 Million |
| Tus Pharmaceutical Group Co Ltd (000590) | $231.22 Million | -38.13% | 1.23x | $389.67 Million |
| Northeast Pharmaceutical Group Co Ltd (000597) | $4.29 Billion | 2.31% | 2.07x | $1.03 Billion |
| Jilin Aodong Pharmaceutical Group Co Ltd (000623) | $18.87 Billion | 8.83% | 0.08x | $3.32 Billion |
About Shanghai Jiaoda Onlly Co Ltd
Shanghai Jiaoda Onlly Co.,Ltd, together with its subsidiaries, engages in the research, development, and production of raw materials and end products of food and health food in China. It is also involved in the operation and management of elderly medical care institutions, including hospitals and nursing homes; and the provision of management consulting services to non-profit hospitals, nursing h… Read more